Sildenafil treatment of primary pulmonary hypertension

Canadian Respiratory Journal

Volumn 10, Issue 1, 2003, Pages 48-50

  Laupland, Kevin B ^a   Helmersen, Doug ^a   Zygun, David A ^a   Viner, Sidney M ^a  

^a CALGARY HEALTH REGION   (Canada)

Author keywords

Nitric oxide; Phosphodiesterase inhibitors; Prostacyclin; Pulmonary hypertension; Pulmonary vasodilator; Sildenafil

Indexed keywords

ANTICOAGULANT AGENT; NIFEDIPINE; NITRIC OXIDE; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT; WARFARIN;

ADULT; AIRWAY OBSTRUCTION; ARTERY CATHETERIZATION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DYSPNEA; FEMALE; HUMAN; HYPOTENSION; LABORATORY TEST; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; MEDICAL DECISION MAKING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SPIROMETRY; SYMPTOMATOLOGY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0347722639     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/612905     Document Type: Article

References (6)

1. Wilkens H, Guth A, Konig J, et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 2001;104:1218-22.
2. Abrams D, Schulze-Neick I, Magee A. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000;84:e4.
3. Prasad S, Wilkinson J, Gatzoulis M. Sildenafil in pulmonary hypertension. N Engl J Med 2000;343:1342. (Lett)
4. Mychaskiw G, Sachdev V, Heath B. Sildenafil (Viagra) weaning of inhaled nitric oxide following placement of a biventricular-assist device. J Clin Anesth 2001;13:218-20.
5. Bigatello L, Hess D, Dennehy KC, et al. Sildenafil can increase the response to inhaled nitric oxide. Anesthesiology 2000;92:1827-9.
6. Zhao L, Mason NA, Morrell, NW, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001;104:424-8.